Breaking News Instant updates and real-time market news.

2021-03-04 16:03:05 VRAY ViewRay $4.16 / -0.09 (-2.12%) 16:03 03/04/21 03/04 16:03 03/04/21 16:03	ViewRay not providing guidance at this time Due to the ongoing impact and uncertainty of the COVID-19 pandemic globally, the company will not be providing financial guidance at this time.	04 Mar 18 Mar 23 Mar 05 Jan 22 Jan
VRAY ViewRay $4.16 / -0.09 (-2.12%) 01/12/21 Piper Sandler ViewRay price target raised to $7 from $4 at Piper Sandler 01/04/21 Piper Sandler Piper Sandler remains 'positively inclined' on ViewRay after preliminary results 11/06/20 Piper Sandler ViewRay price target raised to $4 from $3.50 at Piper Sandler 10/28/20 Fly Intel: Top five analyst upgrades

2021-03-04 16:03:05

VRAY

ViewRay

$4.16 / -0.09 (-2.12%)

16:03

03/04/21

03/04

16:03

03/04/21

16:03

ViewRay not providing guidance at this time

Due to the ongoing impact and uncertainty of the COVID-19 pandemic globally, the company will not be providing financial guidance at this time.

04
Mar
18
Mar
23
Mar

05
Jan
22
Jan

VRAY ViewRay

$4.16 / -0.09 (-2.12%)

01/12/21 Piper Sandler: ViewRay price target raised to $7 from $4 at Piper Sandler

01/04/21 Piper Sandler: Piper Sandler remains 'positively inclined' on ViewRay after preliminary results

11/06/20 Piper Sandler: ViewRay price target raised to $4 from $3.50 at Piper Sandler

10/28/20: Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Hot Stocks	Roche confirms REGN-COV 2069 trial met primary and key secondary endpoints » 08:43 04/12/21 04/12 08:43 04/12/21 08:43 RHHBY Roche $41.93 / +0.53 (+1.28%) , REGN Regeneron $475.52 / -0.61 (-0.13%) Roche (RHHBY) confirmed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 07:05 Today IGM Biosciences appoints George Gauthier as chief commercial officer 04/05/21 Prothena appoints Hideki Garren as chief medical officer 04/01/21 PTC Therapeutics to receive $20M commercial milestone payment from Roche 03/30/21 Roche announces European Commission approval of Evrysdi REGN Regeneron $475.52 / -0.61 (-0.13%) 05:28 Today Regeneron announces second REGEN-COV trial meets primary endpoint 05:24 Today Regeneron announces REGEN-COV trial meets primary, secondary endpoints 04/09/21 Regeneron: NIH COVID-19 guidelines strongly recommend use of REGEN-COV 04/01/21 FDA approves Praluent as on add-on therapy for adult patients with HoFH RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 08:33 Today B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/29/21 RBC Capital PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation 03/25/21 Wedbush iTeos Therapeutics price target raised to $52 from $46 at Wedbush 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback REGN Regeneron $475.52 / -0.61 (-0.13%) 03/24/21 Canaccord Regeneron trial shows positive results against COVID-variants, says Canaccord 03/23/21 Piper Sandler Regeneron lower dose cocktail likely to be added to EUA, says Piper Sandler 03/11/21 Evercore ISI Kodiak Sciences initiated with an Outperform at Evercore ISI 03/11/21 Needham Vir Biotechnology price target raised to $80 from $75 at Needham RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year REGN Regeneron $475.52 / -0.61 (-0.13%) 02/05/21 Regeneron reports Q4 EPS $9.53, consensus $8.39 02/04/21 Notable companies reporting before tomorrow's open 02/04/21 Notable companies reporting before tomorrow's open 11/05/20 Regeneron reports Q3 EPS $8.36, consensus $7.13 27 May RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 03/20/21 Still reasons to be hopeful about Lilly, Biogen Alzheimer's drugs, Barron's says 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says REGN Regeneron $475.52 / -0.61 (-0.13%) 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/04/20 Regeneron must face DOJ suit citing kickbacks, Bloomberg says 11/17/20 Regeneron says Roche completed early tests to make COVID drug, Reuters says RHHBY REGN RHHBY Roche $41.93 / +0.53 (+1.28%) 03/23/21 Fly Intel: Wall Street's top stories for Tuesday 03/23/21 Ionis Pharmaceuticals slides as Wall Street digests HD program setback 03/23/21 Fly Intel: Wall Street's top stories at midday 03/23/21 Fly Intel: Pre-market Movers REGN Regeneron $475.52 / -0.61 (-0.13%) 02/05/21 Fly Intel: Pre-market Movers 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021 05/06/21 Regeneron - REGN 10/21/21 PDUFA Date for Dupixent (Dupilumab) 06/11/21 Regeneron Pharmaceuticals REGN REGN Regeneron $475.52 / -0.61 (-0.13%) 01/13/21 Early notable gainers among liquid option names on January 13th 12/18/20 Early notable gainers among liquid option names on December 18th 11/06/20 Regeneron put volume heavy and directionally bearish
Hot Stocks	GTEC Holdings repays $6M loan, eliminates all debt » 08:41 04/12/21 04/12 08:41 04/12/21 08:41 GGTTF GTEC Holdings / + GTEC is pleased to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News GGTTF GTEC Holdings / + 03/01/21 GTEC Holdings repays convertible debt in full
Hot Stocks	Popular raises dividend to 45c per share, announces $350M stock repurchase plan » 08:40 04/12/21 04/12 08:40 04/12/21 08:40 BPOP Popular $71.50 / +0.27 (+0.38%) Popular announced an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BPOP Popular $71.50 / +0.27 (+0.38%) 02/24/21 Popular VP Gilberto Monzon sells over $325K in shares 10/28/20 Popular implements branch realignment in New York metro region BPOP Popular $71.50 / +0.27 (+0.38%) 01/29/21 RBC Capital Popular price target raised to $70 from $48 at RBC Capital 01/08/21 UBS Popular upgraded to Buy from Neutral at UBS 09/22/20 Top five analyst initiations 09/22/20 UBS Popular initiated with a Neutral at UBS BPOP Popular $71.50 / +0.27 (+0.38%) 01/28/21 Popular reports Q4 EPS $2.10, consensus $1.54 10/28/20 Popular reports Q3 EPS $2.00, consensus $1.20 04/28/21 Popular - BPOP
Hot Stocks	Lottery.com signs engagement letter with Ritzio International » 08:39 04/12/21 04/12 08:39 04/12/21 08:39 TDAC Trident Acquisitions Corp. $13.27 / +0.345 (+2.67%) Lottery.com has signed an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News TDAC Trident Acquisitions Corp. $13.27 / +0.345 (+2.67%) 04/05/21 Lottery.com acquires domain Sports.com 04/01/21 Lottery.com appoints Katie Lever as CLO 03/29/21 Lottery.com enters agreement with Payday Lotteries, offer products in Nigeria 03/22/21 Lottery.com to acquire JeugaLotto, Aganar, terms not disclosed
Earnings	CACI Names Glenn Kurowski CTO » 08:39 04/12/21 04/12 08:39 04/12/21 08:39 CACI CACI $251.61 / +2.4 (+0.96%) CACI International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CACI CACI $251.61 / +2.4 (+0.96%) 04/08/21 CACI gets $700M BPA from the U.S. Department of Homeland Security 04/01/21 CACI awarded $372.85M USSOCOM contract 03/12/21 CACI announces $500M accelerated share repurchase program 03/11/21 CACI announces $500M accelerated share repurchase program CACI CACI $251.61 / +2.4 (+0.96%) 03/26/21 Stifel Stifel downgrades SAIC to Hold after 'materially reset' expectations 02/23/21 William Blair William Blair reiterates Outperform on Leidos following quarterly results 01/29/21 Truist CACI price target raised to $290 from $275 at Truist 01/27/21 Stifel CACI 'very likely' to bid on Perspecta as well, says Stifel CACI CACI $251.61 / +2.4 (+0.96%) 01/27/21 CACI sees FY21 EPS $14.47-$15.25, consensus $15.01 01/27/21 CACI reports Q2 EPS $4.18, consensus $3.60 10/28/20 CACI raises FY21 EPS view to $14.47-$15.25 from $13.50-$14.28 10/28/20 CACI reports Q1 EPS $3.67, consensus $3.11 04/22/21 CACI - CACI

Hot Stocks	Allogene, Springworks announce first patient dosed in Phase 1 study of ALLO-715 » 08:38 04/12/21 04/12 08:38 04/12/21 08:38 ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) , SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) Allogene Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ALLO SWTX ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) 04/11/21 Allogene presents preclinical data expanding utility of TurboCAR platform 12/23/20 Allogene receives IND clearance from FDA for ALLO-715, nirogacestat combination 12/15/20 Allogene Therapeutics, Overland Pharmaceuticals form joint venture in China 12/07/20 Allogene Therapeutics presents preclinical findings on ALLO-605 SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) 04/01/21 SpringsWorks Therapeutics doses first patient in Phase 1b nirogacestat study 03/22/21 SpringsWorks Therapeutics names Bhavesh Ashar as Chief Commercial Officer 02/25/21 SpringsWorks reports results from Phase 2b ReNeu trial of mirdametinib 12/15/20 SpringsWorks Therapeutics promotes Badreddin Edris to COO ALLO SWTX ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) 03/01/21 H.C. Wainwright Allogene Therapeutics price target raised to $43 from $40 at H.C. Wainwright 01/26/21 Stifel Allogene Therapeutics upgraded to Buy from Hold at Stifel 12/28/20 H.C. Wainwright SpringsWorks Therapeutics price target raised to $87 from $73 at H.C. Wainwright 12/10/20 H.C. Wainwright Allogene Therapeutics assumed with a Buy at H.C. Wainwright SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) 03/30/21 JPMorgan SpringsWorks Therapeutics added to Analyst Focus List at JPMorgan 02/26/21 Barclays SpringsWorks Therapeutics price target raised to $105 from $92 at Barclays 02/25/21 H.C. Wainwright SpringsWorks price target raised to $124 from $101 at H.C. Wainwright 01/22/21 Barclays SpringsWorks Therapeutics price target raised to $92 from $83 at Barclays ALLO SWTX ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) 11/04/20 Allogene Therapeutics reports Q3 EPS (52c), consensus (54c) SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) 02/25/21 SpringsWorks Therapeutics reports Q4 EPS 24c, consensus (10c) 11/12/20 SpringsWorks Therapeutics reports Q3 EPS (51c), consensus (48c) 02 Mar 08 Oct 02 Jun ALLO ALLO Allogene Therapeutics $32.83 / -0.83 (-2.47%) 11/04/20 Fly Intel: Wall Street's top stories for Wednesday 11/04/20 Fly Intel: Wall Street's top stories at midday SWTX SWTX SpringsWorks Therapeutics $69.00 / -2.23 (-3.13%) 04/08/21 Five new option listings and one option delisting on April 8th
General news	Fed Chair Powell reiterated the FOMC will continue to support the recovery » 08:38 04/12/21 04/12 08:38 04/12/21 08:38 $ECON Economic Data / + Fed Chair Powell… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Downgrade	Argo Group downgraded to Neutral from Outperform at Boenning & Scattergood » 08:38 04/12/21 04/12 08:38 04/12/21 08:38 ARGO Argo Group $54.05 / -0.13 (-0.24%) Boenning &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ARGO Argo Group $54.05 / -0.13 (-0.24%) 02/17/21 Argo Group reports Q4 combined ratio 110.0% vs. 126.7% last year 02/08/21 Argo Group names Scott Kirk as new CFO effective March 1st 02/02/21 Argo Group estimates Q4 catastrophe losses at $38M 12/23/20 Argo Group announces sale of Italian business, terms not disclosed ARGO Argo Group $54.05 / -0.13 (-0.24%) 03/15/21 HSBC Argo Group price target raised to $10.25 from $7 at HSBC 03/15/21 Compass Point Argo Group upgraded to Buy from Neutral at Compass Point 01/06/21 Compass Point Argo Group price target raised to $47 from $41 at Compass Point 11/11/20 Compass Point Argo Group downgraded to Neutral after vaccine-fueled rally at Compass Point ARGO Argo Group $54.05 / -0.13 (-0.24%) 02/17/21 Argo Group reports Q4 EPS (57c), consensus (39c) 11/02/20 Argo Group reports Q3 EPS (91c), consensus (62c) 05/04/21 Argo Group - ARGO
Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners
Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 02/01/21 Genprex gives update on 2020 developments and anticipated milestones GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners

Hot Stocks	Talend: 'Go-shop' period expires related to Thoma Bravo acquistion » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 TLND Talend $64.71 / +0.27 (+0.42%) Talend announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TLND Talend $64.71 / +0.27 (+0.42%) 04/01/21 Talend and Thomas Bravo announce expiration of HSR period for tender offer 03/10/21 Talend trading resumes 03/10/21 Talend to resume trading at 9:00am ET 03/10/21 Talend to be acquired by Thoma Bravo at $66 per share in $2.4B cash deal TLND Talend $64.71 / +0.27 (+0.42%) 03/11/21 Fly Intel: Top five analyst downgrades 03/11/21 Needham Talend downgraded to Hold from Buy at Needham 03/10/21 Craig-Hallum Talend go-shop 'could spark interest,' says Craig-Hallum 03/10/21 William Blair Talend downgraded to Market Perform from Outperform at William Blair TLND Talend $64.71 / +0.27 (+0.42%) 02/10/21 Talend guides initial FY21 EPS (89c) to (83c), consensus (75c) 02/10/21 Talend sees Q1 EPS (27c) to (24c), consensus (21c) 02/10/21 Talend reports Q4 EPS (10c), consensus (30c) TLND Talend $64.71 / +0.27 (+0.42%) 03/10/21 Fly Intel: Wall Street's top stories for Wednesday 03/10/21 Fly Intel: Wall Street's top stories at midday 02/10/21 Fly Intel: After-Hours Movers 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry
Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 02/01/21 Genprex gives update on 2020 developments and anticipated milestones 01/13/21 Genprex achieves manufacturing milestone for Reqorsa for upcoming trials GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners
Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 08:37 Today Genprex collaborators report data for REQORSA therapy in NSLC treatment 02/01/21 Genprex gives update on 2020 developments and anticipated milestones 01/13/21 Genprex achieves manufacturing milestone for Reqorsa for upcoming trials 12/22/20 Genprex completes manufacturing scale-up for Reqorsa production GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners
Recommendations	Alibaba named a Research Tactical Idea at Morgan Stanley » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 BABA Alibaba $223.35 / -4.9 (-2.15%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BABA Alibaba $223.35 / -4.9 (-2.15%) 07:54 Today Alibaba affiliate Ant Group announces overhaul 04/10/21 Alibaba fined $2.75B by China for antitrust, vows compliance 03/25/21 SEC begins implementing law that could delist foreign companies like Alibaba 02/16/21 Third Point buys Upstart, exits Caesars in Q4 BABA Alibaba $223.35 / -4.9 (-2.15%) 07:37 Today Raymond James Alibaba price target lowered to $330 from $350 at Raymond James 06:41 Today Mizuho Alibaba antitrust ruling 'removes overhang,' says Mizuho 06:37 Today Citi Alibaba fine could help lift 'overhang' on shares, says Citi 06:36 Today KeyBanc Alibaba price target lowered to $305 from $315 at KeyBanc BABA Alibaba $223.35 / -4.9 (-2.15%) 02/02/21 Alibaba reports Q3 EPS $3.38, consensus $3.25 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 11/05/20 Alibaba reports Q2 adjusted EPS $2.65, consensus $2.11 BABA Alibaba $223.35 / -4.9 (-2.15%) 06:18 Today Tencent Music, Meituan concerned after Alibaba's $2.8B fine, FT reports 03/29/21 Energy Monster ownership dispute ahead of U.S. listing, Reuters reports 03/25/21 Ant Group to demand larger fees to rebuild valuation, FT reports 03/23/21 Tencent makes a push for growth, amid China push-back, Bloomberg says BABA Alibaba $223.35 / -4.9 (-2.15%) 03/07/21 Opening Day: InnovAge rises, Oscar Health slips on first trading day 02/28/21 Opening Day: Coinbase files to go public 02/21/21 Opening Day: Podcast app developer Auddia makes public debut 02/14/21 Opening Day: Bumble, Viant soar in market debuts BABA Alibaba $223.35 / -4.9 (-2.15%) 04/07/21 Unusually active option classes on open April 7th 03/10/21 Alibaba call buyer realizes 67% same-day gains 01/08/21 Notable open interest changes for January 8th 12/31/20 Notable open interest changes for December 31st
Hot Stocks	Rayonier Advanced Materials to sell lumber, newsprint assets to GreenFirst » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 RYAM Rayonier Advanced Materials $9.66 / -0.05 (-0.51%) Rayonier Advanced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RYAM Rayonier Advanced Materials $9.66 / -0.05 (-0.51%) 03/01/21 Rayonier Advanced Materials rises 18.8% 03/01/21 Rayonier Advanced Materials rises 16.1% 01/13/21 Element Fleet appoints Frank Ruperto as CFO 11/25/20 Rayonier Advanced Materials falls -10.1% RYAM Rayonier Advanced Materials $9.66 / -0.05 (-0.51%) 10/20/20 Fly Intel: Top five analyst upgrades 10/20/20 RBC Capital Rayonier Advanced Materials upgraded to Outperform at RBC Capital 10/20/20 RBC Capital Rayonier Advanced upgraded to Outperform from Sector Perform at RBC Capital 06/19/20 Fly Intel: Top five analyst upgrades RYAM Rayonier Advanced Materials $9.66 / -0.05 (-0.51%) 02/24/21 Rayonier Advanced Materials reports Q4 EPS 14c, consensus (10c) 11/04/20 Rayonier Advanced Materials reports Q3 ops EPS 45c, consensus (14c) RYAM Rayonier Advanced Materials $9.66 / -0.05 (-0.51%) 11/04/20 Fly Intel: After-Hours Movers 05/17/21 Rayonier Advanced Materials Inc.

Hot Stocks	TC Energy announces issuance of renewable energy RFI » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 TRP TC Energy $46.80 / -0.24 (-0.51%) TC Energy Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events TRP TC Energy $46.80 / -0.24 (-0.51%) 03/03/21 TC Energy, TC PipeLines complete merger 02/26/21 TC PipeLines, TC Energy announce unitholder approval for merger 02/23/21 Energy Income Partners sends letter to board of TC PipeLines 02/22/21 TC PipeLines recommends unitholders vote for TC Energy merger TRP TC Energy $46.80 / -0.24 (-0.51%) 03/19/21 Evercore ISI TC Energy resumed with an In Line at Evercore ISI 03/01/21 Wells Fargo TC PipeLines downgraded to Equal Weight from Overweight at Wells Fargo 02/19/21 TD Securities TC Energy price target lowered to C$73 from C$75 at TD Securities 02/19/21 CIBC TC Energy price target raised to C$70 from C$69 at CIBC TRP TC Energy $46.80 / -0.24 (-0.51%) 02/18/21 TC Energy reports Q4 comparable EPS $1.15, consensus 67c 10/29/20 TC Energy reports Q3 comparable EPS C$0.95, consensus C$0.94 TRP TC Energy $46.80 / -0.24 (-0.51%) 01/21/21 TC Energy to eliminate 1,000 construction positions, halt KXL work, Reuters says 01/18/21 Canada scrambles to salvage Keystone XL, Reuters reports 01/17/21 Biden indicates plans to cancel Keystone XL pipeline permit, CBC News says 06/22/21 2021 Energy, Power & Renewables Virtual Conference
Hot Stocks	Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37 04/12/21 04/12 08:37 04/12/21 08:37 GNPX Genprex $4.46 / -0.415 (-8.51%) Genprex announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNPX Genprex $4.46 / -0.415 (-8.51%) 02/01/21 Genprex gives update on 2020 developments and anticipated milestones 01/13/21 Genprex achieves manufacturing milestone for Reqorsa for upcoming trials 12/22/20 Genprex completes manufacturing scale-up for Reqorsa production 11/30/20 Genprex initiates site recruitment for Acclaim-1 clinical trial GNPX Genprex $4.46 / -0.415 (-8.51%) 01/26/21 National Securities Genprex initiated with a Buy at National Securities 04/22/20 Alliance Global Partners Genprex initiated with a Buy at Alliance Global Partners
Hot Stocks	Medigus says Polyrizon commences pre-clinical study of bio-gel » 08:35 04/12/21 04/12 08:35 04/12/21 08:35 MDGS Medigus $2.03 / -0.035 (-1.70%) Medigus announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Syndicate MDGS Medigus $2.03 / -0.035 (-1.70%) 04/08/21 Medigus says Eventer Technologies secured $2.25M in pre-IPO funding round 03/24/21 Medigus says ScoutCam announces $20M private placement 03/16/21 Medigus says Charging Robotic signs MOU for robotic charging pad distribution 03/08/21 Medigus says ScoutCam appoints Yovav Sameah as CEO 11 Jan 02 Dec 20 May
Hot Stocks	Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B » 08:35 04/12/21 04/12 08:35 04/12/21 08:35 MSFT Microsoft $255.73 / +2.37 (+0.94%) , NUAN Nuance $45.59 / +0.38 (+0.84%) Microsoft (MSFT) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MSFT NUAN MSFT Microsoft $255.73 / +2.37 (+0.94%) 08:32 Today Microsoft to acquire Nuance for $56.00 per share in cash 07:56 Today Unisys names Dwayne Allen as Chief Technology Officer 04/11/21 Fly Intel: Top five weekend stock stories 04/08/21 Arkane delays upcoming PS5 game 'Deathloop' to September 14, 2021 NUAN Nuance $45.59 / +0.38 (+0.84%) 08:32 Today Microsoft to acquire Nuance for $56.00 per share in cash 08:04 Today Nuance trading halted, news pending 04/11/21 Fly Intel: Top five weekend stock stories 02/08/21 Nuance says FY21 guidance update reflects government Coding contract extension MSFT NUAN MSFT Microsoft $255.73 / +2.37 (+0.94%) 08:30 Today Stifel Microsoft a 'logical buyer' of Nuance, says Stifel 07:36 Today B. Riley Nuance possible takeout positive for peer LivePerson, says B. Riley 07:29 Today Wedbush Nuance deal would be 'trophy' for Microsoft, says Wedbush 07:11 Today BMO Capital Microsoft price target raised to $280 from $270 at BMO Capital NUAN Nuance $45.59 / +0.38 (+0.84%) 08:30 Today Stifel Microsoft a 'logical buyer' of Nuance, says Stifel 07:36 Today B. Riley Nuance possible takeout positive for peer LivePerson, says B. Riley 07:29 Today Wedbush Nuance deal would be 'trophy' for Microsoft, says Wedbush 03/10/21 Wedbush Nuance added to Best Ideas List at Wedbush MSFT NUAN MSFT Microsoft $255.73 / +2.37 (+0.94%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B NUAN Nuance $45.59 / +0.38 (+0.84%) 02/08/21 Nuance raises FY21 revenue view to $1.34B-$1.38B from $1.33B-$1.37B 02/08/21 Nuance sees Q2 EPS 14c-18c, consensus 18c 02/08/21 Nuance reports Q1 adjusted EPS 20c, consensus 18c 11/18/20 Nuance says FY21 guidance reflects continuing Enterprise revenue growth MSFT NUAN MSFT Microsoft $255.73 / +2.37 (+0.94%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says 04/09/21 Hackers scraped data of 500M LinkedIn users, Insider reports 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 04/01/21 LinkedIn testing Clubhouse competitor, Business Insider reports NUAN Nuance $45.59 / +0.38 (+0.84%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says MSFT NUAN MSFT Microsoft $255.73 / +2.37 (+0.94%) 04/07/21 Game On: An exclusive talk with 'Genesis Noir' developer Feral Cat Den 04/05/21 Roblox jumps as several Wall Street analysts initiate coverage with a Buy 03/31/21 Fly Intel: Wall Street's top stories for Wednesday 03/24/21 Street Fight: Analysts diverge on Intel following 'Unleashed' event NUAN Nuance $45.59 / +0.38 (+0.84%) 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 02/08/21 Fly Intel: After-Hours Movers 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Technology, Media & Communications Virtual Conference MSFT NUAN MSFT Microsoft $255.73 / +2.37 (+0.94%) 04/06/21 Microsoft call buyer realizes 130% same-day gains 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th NUAN Nuance $45.59 / +0.38 (+0.84%) 04/07/21 Nuance call volume above normal and directionally bullish 03/23/21 Nuance call buyer realizes 9% same-day gains 02/08/21 Nuance options imply 10.5% move in share price post-earnings
General news	Oil Action: WTI crude » 08:35 04/12/21 04/12 08:35 04/12/21 08:35 $ECON Economic Data / + Oil Action: WTI crude is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><<

Hot Stocks	Artelo Biosciences doses first patient in CAReS study with ART27.13 » 08:34 04/12/21 04/12 08:34 04/12/21 08:34 ARTL Artelo Biosciences $1.53 / -0.055 (-3.47%) Artelo Biosciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate ARTL Artelo Biosciences $1.53 / -0.055 (-3.47%) 03/19/21 Artelo Biosciences accepted into Alderly Park Oncology Development Program 03/09/21 Artelo Biosciences appoints Tamara Seymour to board of directors 02/17/21 Artelo Biosciences announces pre-clinical data on CBD Cocrystal 02/16/21 Artelo Biosciences names Andrew Yates as chief scientific officer ARTL Artelo Biosciences $1.53 / -0.055 (-3.47%) 02/12/21 Ladenburg Artelo Biosciences initiated with a Buy at Ladenburg 01/07/21 Maxim Artelo Biosciences upgraded to Buy from Hold at Maxim 01/07/21 Maxim Artelo Biosciences upgraded to Buy from Hold at Maxim 05/13/20 Maxim Artelo Biosciences downgraded to Hold from Buy at Maxim ARTL Artelo Biosciences $1.53 / -0.055 (-3.47%) 01/14/21 Artelo Biosciences reports Q1 EPS (14c), one est. (10c) 11/04/20 Artelo Biosciences reports FY20 EPS ($1.26) vs. ($1.00) last year 09 Oct
Recommendations	Chicken Soup for the Soul price target raised to $48 from $35 at Craig-Hallum » 08:34 04/12/21 04/12 08:34 04/12/21 08:34 CSSE Chicken Soup for the Soul $32.50 / +4.54 (+16.24%) Craig-Hallum analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events CSSE Chicken Soup for the Soul $32.50 / +4.54 (+16.24%) 04/09/21 Chicken Soup for the Soul to aquire film, TV assets of Sonar Entertainment 03/22/21 Chicken Soup announces expanded distribution rollout of Crackle Plus networks 03/11/21 Chicken Soup for the Soul's Crackle Plus expands agreement with Plex 03/10/21 Chicken Soup for the Soul's Crackle Plus signs agreement for Vewd smart TVs CSSE Chicken Soup for the Soul $32.50 / +4.54 (+16.24%) 08:23 Today Northland Chicken Soup for the Soul price target raised to $40 from $30 at Northland 04/09/21 Alliance Global Partners Alliance Global raises Chicken Soup for the Soul price target to $48 after deal 04/01/21 DA Davidson Chicken Soup for the Soul price target raised to $34 from $28 at DA Davidson 04/01/21 Craig-Hallum Chicken Soup for the Soul price target raised to $35 from $30 at Craig-Hallum 05/24/21 Global Technology, Media & Communications Virtual Conference
Hot Stocks	Infinity Energy completes purchase of production, acresin Central Kansas Uplift » 08:33 04/12/21 04/12 08:33 04/12/21 08:33 IFNY Infinity Energy Resources / + Infinity Energy Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	B. Riley calls Agenus the next Seagen, reiterates $8 target » 08:33 04/12/21 04/12 08:33 04/12/21 08:33 AGEN Agenus $2.78 / -0.01 (-0.36%) , MRK Merck $76.33 / +0.855 (+1.13%) , BMY Bristol-Myers $62.61 / +0.695 (+1.12%) , AZN AstraZeneca $49.95 / +0.465 (+0.94%) , RHHBY Roche $41.93 / +0.53 (+1.28%) , SGEN Seagen $142.81 / -1.68 (-1.16%) B. Riley analyst Mayank… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AGEN MRK BMY AZN RHHBY SGEN AGEN Agenus $2.78 / -0.01 (-0.36%) 04/11/21 Agenus presents new clinical data on AGEN1181 at AACR Meeting 03/10/21 Agenus to present new clinical data on AGEN1181 at AACR 02/09/21 Agenus names Andy Hurley chief commercial officer 02/09/21 Agenus announces new responses for AGEN1181 MRK Merck $76.33 / +0.855 (+1.13%) 04/08/21 Immutep achieves fast track designation from FDA for Efti 04/08/21 Merck says Phase 3 KEYNOTE-564 trial met primary endpoint 04/07/21 Alkermes announces nemvaleukin trial collaboration, supply agreement with Merck 04/07/21 IMV Inc. enters agreement with Merck to initiate maveropepimut-S, Keytruda trial BMY Bristol-Myers $62.61 / +0.695 (+1.12%) 04/11/21 Bristol-Myers announces results from CheckMate -816 study 04/08/21 Bristol-Myers reports 'positive' results from Phase 3 CheckMate -648 trial 04/01/21 Agios Pharmaceuticals enters agreement to repurchase stock from Bristol-Myers 03/30/21 Huyabio International enters clinical collaboration agreement with Bristol-Myers AZN AstraZeneca $49.95 / +0.465 (+0.94%) 06:09 Today AstraZeneca's DARE-19 ph.3 trial of Farxiga in COVID-19 failed primary endpoint 04/09/21 AstraZeneca to unveil ARP1 selective inhibitor AZD5305 at AACR 04/07/21 MHRA issues new advice, sees possible link between AstraZeneca vaccine and clots 04/07/21 U.K. offers Pfizer, Moderna vaccine to those under 30 with risk conditions RHHBY Roche $41.93 / +0.53 (+1.28%) 07:05 Today IGM Biosciences appoints George Gauthier as chief commercial officer 04/05/21 Prothena appoints Hideki Garren as chief medical officer 04/01/21 PTC Therapeutics to receive $20M commercial milestone payment from Roche 03/30/21 Roche announces European Commission approval of Evrysdi SGEN Seagen $142.81 / -1.68 (-1.16%) 04/09/21 Seagen, Genmab say FDA accepts BLA for tisotumab vedotin for priority review 03/26/21 Astellas Pharma, Seagen announce enfortumab vedotin MAA accepted by EMA 03/25/21 Pieris amend immuno-oncology pact with Seagen 03/05/21 Seagen recommends shareholders reject TRC Capital mini-tender offer AGEN MRK BMY AZN RHHBY SGEN AGEN Agenus $2.78 / -0.01 (-0.36%) 09/22/20 B. Riley FBR B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases 09/18/20 Jefferies Agenus price target raised to $8 from $5 at Jefferies MRK Merck $76.33 / +0.855 (+1.13%) 04/08/21 Alliance Global Partners Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive 04/08/21 H.C. Wainwright Alkermes collaboration not as big as investors wanted, says H.C. Wainwright 04/07/21 Mizuho Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin 04/06/21 RBC Capital Merck transferred with a Sector Perform at RBC Capital BMY Bristol-Myers $62.61 / +0.695 (+1.12%) 03/08/21 BofA Gartner added to US 1 List, Bristol-Myers removed at BofA 02/12/21 Morgan Stanley Amgen court decision may have readthrough for Gilead, says Morgan Stanley 02/02/21 BTIG Prothena upgraded to Buy at BTIG on birtamimab 'revival' 01/20/21 William Blair Exelixis selloff on competitive concerns an 'overreaction,' says William Blair AZN AstraZeneca $49.95 / +0.465 (+0.94%) 07:18 Today Argus AstraZeneca downgraded to Hold from Buy at Argus 07:09 Today Argus AstraZeneca downgraded to Hold from Buy at Argus 04/07/21 Citi FibroGen update creates only 'bad optic' for AstraZeneca, says Citi 03/26/21 Piper Sandler AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler RHHBY Roche $41.93 / +0.53 (+1.28%) 03/29/21 RBC Capital PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation 03/25/21 Wedbush iTeos Therapeutics price target raised to $52 from $46 at Wedbush 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback 03/23/21 BMO Capital Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital SGEN Seagen $142.81 / -1.68 (-1.16%) 03/30/21 Credit Suisse Seagen initiated with a Neutral at Credit Suisse 03/30/21 Credit Suisse Seagen initiated with a Neutral at Credit Suisse 02/16/21 RBC Capital Seagen price target lowered to $169 from $186 at RBC Capital 02/12/21 Barclays Seagen price target lowered to $168 from $177 at Barclays AGEN MRK BMY AZN RHHBY SGEN AGEN Agenus $2.78 / -0.01 (-0.36%) 03/15/21 Agenus reports Q4 EPS (20c), consensus (22c) 10/29/20 Agenus reports Q3 EPS (28c), consensus (26c) MRK Merck $76.33 / +0.855 (+1.13%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open BMY Bristol-Myers $62.61 / +0.695 (+1.12%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 AZN AstraZeneca $49.95 / +0.465 (+0.94%) 04/07/21 EMA says benefits of AstraZeneca Covid vaccine outweigh side effects 02/11/21 AstraZeneca sees FY21 core EPS $4.75-$5.00 02/11/21 AstraZeneca reports Q4 core EPS $1.07, total revenue $7.41B 11/05/20 AstraZeneca backs view for FY20 core EPS up by a mid- to high-teens percentage RHHBY Roche $41.93 / +0.53 (+1.28%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year SGEN Seagen $142.81 / -1.68 (-1.16%) 02/11/21 Seagen reports Q4 EPS 90c, consensus 86c 10/29/20 Seagen reports Q3 EPS $3.50 vs. (55c) last year MRK BMY AZN RHHBY MRK Merck $76.33 / +0.855 (+1.13%) 03/15/21 Gilead, Merck to develop long-acting HIV therapy treatment, WSJ reports 03/10/21 Biden to announce U.S. buying 100M more doses of J&J vaccine, NBC reports 03/08/21 Biden to meet with CEOs of J&J, Merck at White House, Reuters reports 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports BMY Bristol-Myers $62.61 / +0.695 (+1.12%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says AZN AstraZeneca $49.95 / +0.465 (+0.94%) 04/09/21 AstraZeneca slashes vaccine deliveries to EU by 49%, FT reports 04/09/21 EU evaluates J&J vaccine for blood clots, widens AstraZeneca probe, Reuters says 04/08/21 Spain recommends AstraZeneca vaccine for over-60s only, FT reports 04/08/21 Official warned that Emergent plant had to be 'monitored closely,' NYT reports RHHBY Roche $41.93 / +0.53 (+1.28%) 03/20/21 Still reasons to be hopeful about Lilly, Biogen Alzheimer's drugs, Barron's says 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says MRK BMY AZN RHHBY SGEN MRK Merck $76.33 / +0.855 (+1.13%) 03/08/21 Fly Intel: Wall Street's top stories for Monday 03/08/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday BMY Bristol-Myers $62.61 / +0.695 (+1.12%) 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 11/21/20 Week in review: How Trump's policies moved stocks AZN AstraZeneca $49.95 / +0.465 (+0.94%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/07/21 Fly Intel: Wall Street's top stories for Wednesday 04/07/21 FibroGen slides after 'unfavorable disclosure' on safety data for anemia pill RHHBY Roche $41.93 / +0.53 (+1.28%) 03/23/21 Fly Intel: Wall Street's top stories for Tuesday 03/23/21 Ionis Pharmaceuticals slides as Wall Street digests HD program setback 03/23/21 Fly Intel: Wall Street's top stories at midday 03/23/21 Fly Intel: Pre-market Movers SGEN Seagen $142.81 / -1.68 (-1.16%) 02/11/21 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021 04/29/21 Merck - MRK 04/29/21 Bristol-Myers - BMY 04/29/21 Seagen - SGEN 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 04/28/21 Oncologic Drugs Advisory Committee Virtual Meeting 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/06/21 FARXIGA Granted Priority Review for Chronic Kidney Disease 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 07/18/21 PDUFA Date for V114 09/15/21 PDUFA Date for Belzutifan (MK-6482) 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 12/21/21 PDUFA Date for Gefapixant 01/28/22 PDUFA Date for Mavacamten 05/03/21 Merck & Co. Inc. 05/04/21 Bristol Myers Squibb Co 05/25/21 Merck & Co. Inc. MRK BMY AZN MRK Merck $76.33 / +0.855 (+1.13%) 03/02/21 Unusually active option classes on open March 2nd 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish BMY Bristol-Myers $62.61 / +0.695 (+1.12%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish AZN AstraZeneca $49.95 / +0.465 (+0.94%) 04/01/21 AstraZeneca put volume heavy and directionally bearish 03/22/21 AstraZeneca call volume above normal and directionally bullish 03/16/21 Unusually active option classes on open March 16th 02/24/21 AstraZeneca call volume above normal and directionally bullish
Hot Stocks	Homology Medicines announces promotion of Tim Kelly to COO » 08:32 04/12/21 04/12 08:32 04/12/21 08:32 FIXX Homology Medicines $7.30 / -0.17 (-2.28%) Homology Medicines… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events FIXX Homology Medicines $7.30 / -0.17 (-2.28%) 08:32 Today Homology Medicines announces promotion of Tim Kelly to COO 04/06/21 Homology Medicines drops 8% to $8.51 after announcing $50M stock offering 03/01/21 Homology Medicines regains worldwide rights to ophthalmology program 02/08/21 Homology reports first presentation of data from IND-enabling studies of HMI-203 FIXX Homology Medicines $7.30 / -0.17 (-2.28%) 03/01/21 Stifel Homology Medicines initiated with a Hold at Stifel 03/01/21 Oppenheimer Homology Medicines loses potential source of upside, says Oppenheimer 12/14/20 H.C. Wainwright Homology Medicines transferred with Buy, $30 target at H.C. Wainwright 11/08/20 Oppenheimer Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer FIXX Homology Medicines $7.30 / -0.17 (-2.28%) 03/11/21 Homology Medicines reports Q4 EPS (62c), consensus (68c) 11/09/20 Homology Medicines reports Q 3EPS (62c), consensus (80c) 07 Apr FIXX Homology Medicines $7.30 / -0.17 (-2.28%) 04/07/21 Fly Intel: Pre-market Movers 04/06/21 Fly Intel: After-Hours Movers 11/19/20 Fly Intel: After-Hours Movers 04/15/21 FuboTV

Events

Earnings calls, analyst events, roadshows and more

APHA
Today at 09:00

Aphria - APHA Conference Calls
Today at 09:00

Infrastructure Industry Meetings
BBVA
Today at 09:00

European Banking/Financials Industry Meetings
ZLAB
Today at 10:00

Zai Lab - ZLAB Conference Calls
OTCM
Today at 10:00

OTC Markets Group Inc. Firm Sponsored Meetings

Virtual Meeting
Today at 10:00

Retail/Softlines & Dept Stores Industry Meetings
Today at 10:00

Energy Industry Meetings
CRDF
Today at 11:00

Cardiff Oncology - CRDF Conference Calls
GNL
Today at 11:00

Global Net Lease, Inc. Firm Sponsored Meetings
RXT
Today at 11:00

Rackspace Technology Firm Sponsored Meetings

Virtual Roundtable

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

ViewRay not providing guidance at this time

TODAY'S FREE FLY STORIES

Get Full Fly Access